Hepatocellular carcinoma (HCC), with rising incidence rates, is the most commonly
occurring malignancy of the liver that exerts a heavy disease burden particularly in …

Hepatocellular carcinoma (HCC) is one of the leading causes of cancer-related mortalities
worldwide. Patients with early-stage HCC are eligible for curative treatments, such as …

Hepatocellular carcinoma (HCC) is primarily a malignancy of the liver, advancing from a
damaged, cirrhotic liver to HCC. Globally, HCC is the sixth most prevalent cancer and the …

Immune cells constitute an important element of tumor tissue. Accumulating evidence
indicates their clinicopathological significance in predicting prognosis and therapeutic …

Incidence of hepatocellular carcinoma (HCC) is on the rise due to the prevalence of chronic
hepatitis and cirrhosis. Although there are surgical and chemotherapy treatment avenues …

Primary liver cancer includes hepatocellular carcinoma (HCC) and cholangiocarcinoma
(CCA). Incidence of liver cancer has been increasing in recent years, and the 5-year survival …

Objective: Hepatocellular carcinoma (HCC) as a chronic liver condition is largely associated
with immune responses. Previous studies have revealed that different subsets of …

Systematic interrogation of tumor-infiltrating immune cells (TIICs) is key to the prediction of
clinical outcome and development of immunotherapies. However, little is known about the …

Simple Summary In this review, we analyze the contribution of the most abundant immune
cell populations in hepatocellular carcinoma (HCC) progression and response to therapy …

Hepatocellular carcinoma (HCC) is one of the most malignant types of cancer, and is
associated with high recurrence rates and a poor response to chemotherapy. Immune …